Emerging Antithrombotic Therapies

The treatment of thrombotic disorders has seen significant advancements with the development of novel antithrombotic agents. This session will focus on cutting-edge therapies that target key pathways in the coagulation cascade, platelet activation, and fibrin formation. Novel oral anticoagulants (NOACs), including direct thrombin inhibitors and factor Xa inhibitors, have revolutionized anticoagulation therapy, offering more predictable pharmacokinetics and fewer monitoring requirements. Additionally, emerging therapies such as antiplatelet agents targeting P2Y12 receptors, thrombin receptor antagonists, and biologic therapies, hold promise for more effective and personalized treatment options. Discussions will also cover the safety profiles, clinical trials, and future directions in antithrombotic drug development.

    Related Conference of Emerging Antithrombotic Therapies

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Emerging Antithrombotic Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in